| Year |
Citation |
Score |
| 2024 |
Shinzato GT, Assone T, Sandler PC, Pacheco-Barrios K, Fregni F, Radanovic M, Forlenza OV, Battistella LR. Non-invasive sound wave brain stimulation with Transcranial Pulse Stimulation (TPS) improves neuropsychiatric symptoms in Alzheimer's disease. Brain Stimulation. 17: 413-415. PMID 38513821 DOI: 10.1016/j.brs.2024.03.007 |
0.303 |
|
| 2024 |
Singulani MP, Ferreira AFF, Figueroa PS, Cuyul-Vásquez I, Talib LL, Britto LR, Forlenza OV. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease. Ageing Research Reviews. 95: 102231. PMID 38364914 DOI: 10.1016/j.arr.2024.102231 |
0.354 |
|
| 2024 |
Stella F, Pais MV, Loureiro JC, Cordeiro AMT, Talib LL, Forlenza OV. Neuropsychiatric symptoms and ApoE genotype in older adults without dementia: a cross-sectional study. Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society. PMID 38303161 DOI: 10.1111/psyg.13084 |
0.791 |
|
| 2023 |
Conceição ASGG, Sant Ana LFG, Mattar GP, de Fátima R Silva M, Ramos AR, Oliveira AM, Carvalho CL, Gonçalves OR, Varotto BLR, Martinez LD, Leduc V, Fonseca LM, Forlenza OV. Balance and Gait: Associations With Cognitive Impairment and Dementia in Individuals With Down Syndrome. Alzheimer Disease and Associated Disorders. 37: 349-356. PMID 37788381 DOI: 10.1097/WAD.0000000000000580 |
0.397 |
|
| 2023 |
Belan AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, Radanovic M, Forlenza OV. Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 37355905 DOI: 10.3233/JAD-230250 |
0.811 |
|
| 2023 |
Damiano RF, Rocca CCA, Serafim AP, Loftis JM, Talib LL, Pan PM, Cunha-Neto E, Kalil J, de Castro GS, Seelaender M, Guedes BF, Nagahashi Marie SK, de Souza HP, Nitrini R, Miguel EC, ... ... Forlenza OV, et al. Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Frontiers in Immunology. 14: 1174020. PMID 37287969 DOI: 10.3389/fimmu.2023.1174020 |
0.303 |
|
| 2023 |
Pais MV, Forlenza OV, Diniz BS. Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice. Journal of Alzheimer's Disease Reports. 7: 355-380. PMID 37220625 DOI: 10.3233/ADR-230029 |
0.802 |
|
| 2023 |
Magalhães TNC, Casseb RF, Gerbelli CLB, Pimentel-Siva LR, Nogueira MH, Teixeira CVL, Carletti AFMK, de Rezende TJR, Joaquim HPG, Talib LL, Forlenza OV, Cendes F, Balthazar MLF. Whole-brain DTI parameters associated with tau protein and hippocampal volume in Alzheimer's disease. Brain and Behavior. 13: e2863. PMID 36601694 DOI: 10.1002/brb3.2863 |
0.366 |
|
| 2022 |
Schilling LP, Balthazar MLF, Radanovic M, Forlenza OV, Silagi ML, Smid J, Barbosa BJAP, Frota NAF, de Souza LC, Vale FAC, Caramelli P, Bertolucci PHF, Chaves MLF, Brucki SMD, Damasceno BP, et al. Diagnosis of Alzheimer's disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Dementia & Neuropsychologia. 16: 25-39. PMID 36533157 DOI: 10.1590/1980-5764-DN-2022-S102PT |
0.425 |
|
| 2022 |
Carneiro CG, Faria DP, Coutinho AM, Ono CR, Duran FLS, da Costa NA, Garcez AT, da Silveira PS, Forlenza OV, Brucki SMD, Nitrini R, Busatto G, Buchpiguel CA. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 44: 495-506. PMID 36420910 DOI: 10.47626/1516-4446-2021-2374 |
0.341 |
|
| 2022 |
Camargo MVZA, Pais MV, Bellan AFR, Tahira AC, Dos Santos B, Sant'Ana LCFG, Radanovic M, Forlenza OV. Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36093694 DOI: 10.3233/JAD-220385 |
0.803 |
|
| 2022 |
Damiano RF, Loureiro JC, Pais MV, Pereira RF, Corradi MM, Santi TD, Bezerra GAM, Radanovic M, Talib LL, Forlenza OV. Revisiting global cognitive and functional state thirteen years after participation in a clinical trial of lithium for the treatment of mild cognitive impairment. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 36049127 DOI: 10.47626/1516-4446-2022-2767 |
0.812 |
|
| 2022 |
Rizzi L, Cardoso Magalhães TN, Lecce N, Dos Santos Moraes A, Fernandes Casseb R, Vieira Ligo Teixeira C, Machado de Campos B, Junqueira Ribeiro de Rezende T, Leme Talib L, Forlenza OV, Cendes F, Balthazar MLF. Cholinesterase Inhibitors Response Might Be Related to Right Hippocampal Functional Connectivity in Mild Alzheimer's Disease. Brain Connectivity. PMID 35994390 DOI: 10.1089/brain.2022.0026 |
0.377 |
|
| 2022 |
Costa A, Pais M, Loureiro J, Stella F, Radanovic M, Gattaz W, Forlenza O, Talib L. Decision tree-based classification as a support to diagnosis in the Alzheimer's disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 35739065 DOI: 10.47626/1516-4446-2021-2277 |
0.822 |
|
| 2022 |
Loureiro JC, Silva LFAL, Pais MV, Forlenza OV. Anti-amyloid agents for treating incipient Alzheimer's disease: a new hope? Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 35729067 DOI: 10.47626/1516-4446-2022-2503 |
0.79 |
|
| 2022 |
Lourenço RB, Campos BM, Rizzi L, de Souza MS, Forlenza OV, Talib LL, Joaquim HPG, Cendes F, Balthazar MLF. Functional connectome analysis in Mild Cognitive Impairment: Comparing AD continuum and Suspected Non-Alzheimer Pathology. Brain Connectivity. PMID 35412854 DOI: 10.1089/brain.2021.0154 |
0.455 |
|
| 2022 |
Prado Mattar G, Uchida RR, Haddad GG, Shiozawa P, Rebouças da Silva MF, Hoexter MQ, Busatto GF, de Campos Bottino CM, Fonseca LM, Forlenza OV. Screening for Dementia and Cognitive Decline in Adults With Down Syndrome: A Novel Approach Using the Informant Questionnaire on Cognitive Decline in the Elderly. Alzheimer Disease and Associated Disorders. 36: 162-167. PMID 35293379 DOI: 10.1097/WAD.0000000000000495 |
0.35 |
|
| 2022 |
Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de Pádua Serafim A, Bacchi P, Guedes BF, Brunoni AR, Pan PM, Nitrini R, Beach S, Fricchione G, Busatto G, Miguel EC, Forlenza OV. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study. General Hospital Psychiatry. 75: 38-45. PMID 35134702 DOI: 10.1016/j.genhosppsych.2022.01.002 |
0.344 |
|
| 2022 |
Brum PS, Forlenza OV, Yassuda MS. Cognitive training in older adults with Mild Cognitive Impairment: Impact on cognitive and functional performance. Dementia & Neuropsychologia. 3: 124-131. PMID 29213623 DOI: 10.1590/S1980-57642009DN30200010 |
0.351 |
|
| 2021 |
Stella F, Pais MV, Loureiro JC, Radanovic M, Forlenza OV. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C). Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society. 22: 55-66. PMID 34704636 DOI: 10.1111/psyg.12776 |
0.817 |
|
| 2021 |
Maziero MP, Belan AFR, Camargo MVZA, Silagi ML, Forlenza OV, Radanovic M. Textual Inference Comprehension in Mild Cognitive Impairment: The Influence of Semantic Processing and Verbal Episodic Memory. Frontiers in Aging Neuroscience. 13: 735633. PMID 34675798 DOI: 10.3389/fnagi.2021.735633 |
0.352 |
|
| 2021 |
Magalhães TNC, Gerbelli CLB, Pimentel-Silva LR, de Campos BM, de Rezende TJR, Rizzi L, Joaquim HPG, Talib LL, Forlenza OV, Cendes F, Balthazar MLF. Differences in structural and functional default mode network connectivity in amyloid positive mild cognitive impairment: a longitudinal study. Neuroradiology. 64: 141-150. PMID 34278511 DOI: 10.1007/s00234-021-02760-5 |
0.416 |
|
| 2021 |
Damiano RF, Guedes BF, de Rocca CC, de Pádua Serafim A, Castro LHM, Munhoz CD, Nitrini R, Filho GB, Miguel EC, Lucchetti G, Forlenza O. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience. PMID 34173049 DOI: 10.1007/s00406-021-01286-4 |
0.318 |
|
| 2021 |
Cecchini MA, Yassuda MS, Squarzoni P, Coutinho AM, de Paula Faria D, Duran FLS, Costa NAD, Porto FHG, Nitrini R, Forlenza OV, Brucki SMD, Buchpiguel CA, Parra MA, Busatto GF. Deficits in short-term memory binding are detectable in individuals with brain amyloid deposition in the absence of overt neurodegeneration in the Alzheimer's disease continuum. Brain and Cognition. 152: 105749. PMID 34022637 DOI: 10.1016/j.bandc.2021.105749 |
0.353 |
|
| 2021 |
Pais M, Loureiro J, do Vale V, Radanovic M, Talib L, Stella F, Forlenza O. Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study. Journal of Alzheimer's Disease : Jad. 81: 949-962. PMID 33843685 DOI: 10.3233/JAD-210144 |
0.82 |
|
| 2021 |
Loureiro JC, Pais MV, Forlenza OV. Cognitive impairment: an (in)dependent risk factor for mortality in older men? Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 42: 577-578. PMID 32876138 DOI: 10.1590/1516-4446-2020-0017 |
0.792 |
|
| 2020 |
Busatto GF, de Gobbi Porto FH, Faria DP, Squarzoni P, Coutinho AM, Garcez AT, Rosa PGP, da Costa NA, Carvalho CL, Torralbo L, de Almeida Hernandes JR, Ono CR, Brucki SMD, Nitrini R, Buchpiguel CA, ... ... Forlenza OV, et al. imaging evidence of poor cognitive resilience to Alzheimer's disease pathology in subjects with very low cognitive reserve from a low-middle income environment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12122. PMID 33426265 DOI: 10.1002/dad2.12122 |
0.421 |
|
| 2020 |
Penteado CT, Loureiro JC, Pais MV, Carvalho CL, Sant'Ana LFG, Valiengo LCL, Stella F, Forlenza OV. Mental Health Status of Psychogeriatric Patients During the 2019 New Coronavirus Disease (COVID-19) Pandemic and Effects on Caregiver Burden. Frontiers in Psychiatry. 11: 578672. PMID 33312138 DOI: 10.3389/fpsyt.2020.578672 |
0.781 |
|
| 2020 |
Squarzoni P, Faria DP, Yassuda MS, Porto FHG, Coutinho AM, Costa NAD, Nitrini R, Forlenza OV, Duran FLS, Brucki SMD, Buchpiguel CA, Busatto GF. Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects. Journal of Alzheimer's Disease : Jad. PMID 32986673 DOI: 10.3233/JAD-200758 |
0.401 |
|
| 2020 |
Ibarra R, Radanovic M, Pais MV, Talib LL, Forlenza OV. AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State. Journal of Geriatric Psychiatry and Neurology. 34: 659-667. PMID 32757819 DOI: 10.1177/0891988720944237 |
0.84 |
|
| 2020 |
Loureiro JC, Stella F, Pais MV, Radanovic M, Canineu PR, Joaquim HPG, Talib LL, Forlenza OV. Cognitive impairment in remitted late-life depression is not associated with Alzheimer's disease-related CSF biomarkers. Journal of Affective Disorders. 272: 409-416. PMID 32553384 DOI: 10.1016/j.jad.2020.03.166 |
0.846 |
|
| 2020 |
Pereira MLGF, Camargo MVZA, Bellan AFR, Tahira AC, Dos Santos B, Dos Santos J, Machado-Lima A, Nunes FLS, Forlenza OV. Visual Search Efficiency in Mild Cognitive Impairment and Alzheimer's Disease: An Eye Movement Study. Journal of Alzheimer's Disease : Jad. PMID 32250291 DOI: 10.3233/JAD-190690 |
0.374 |
|
| 2020 |
Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, de Souza LC. Passive antiamyloid immunotherapy for Alzheimer's disease. Current Opinion in Psychiatry. PMID 32040044 DOI: 10.1097/YCO.0000000000000587 |
0.789 |
|
| 2020 |
Pais M, Martinez L, Ribeiro O, Loureiro J, Fernandez R, Valiengo L, Canineu P, Stella F, Talib L, Radanovic M, Forlenza OV. Early diagnosis and treatment of Alzheimer's disease: new definitions and challenges. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 31994640 DOI: 10.1590/1516-4446-2019-0735 |
0.792 |
|
| 2020 |
Radanovic M, Oshiro CA, Freitas TQ, Talib LL, Forlenza OV. Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 41: 479-484. PMID 31166546 DOI: 10.1590/1516-4446-2018-0296 |
0.451 |
|
| 2020 |
de Paula VJR, Guimarães FM, Diniz BS, Forlenza OV. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both? Dementia & Neuropsychologia. 3: 188-194. PMID 29213627 DOI: 10.1590/S1980-57642009DN30300003 |
0.745 |
|
| 2019 |
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European Archives of Psychiatry and Clinical Neuroscience. PMID 31218445 DOI: 10.1007/S00406-019-01034-9 |
0.476 |
|
| 2019 |
Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. The British Journal of Psychiatry : the Journal of Mental Science. 1-7. PMID 30947755 DOI: 10.1192/Bjp.2019.76 |
0.426 |
|
| 2018 |
Teixeira CVL, Ribeiro de Rezende TJ, Weiler M, Magalhães TNC, Carletti-Cassani AFMK, Silva TQAC, Joaquim HPG, Talib LL, Forlenza OV, Franco MP, Nechio PE, Fernandes PT, Cendes F, Figueredo Balthazar ML. Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training. Alzheimer's & Dementia (New York, N. Y.). 4: 473-480. PMID 30258976 DOI: 10.1016/j.trci.2018.02.003 |
0.42 |
|
| 2018 |
Weiler M, Casseb RF, de Campos BM, de Ligo Teixeira CV, Carletti-Cassani AFMK, Vicentini JE, Magalhães TNC, de Almeira DQ, Talib LL, Forlenza OV, Balthazar MLF, Castellano G. Cognitive Reserve Relates to Functional Network Efficiency in Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 255. PMID 30186154 DOI: 10.3389/fnagi.2018.00255 |
0.413 |
|
| 2018 |
Bram JMF, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European Archives of Psychiatry and Clinical Neuroscience. PMID 29845446 DOI: 10.1007/S00406-018-0905-3 |
0.306 |
|
| 2018 |
Radanovic M, Facco G, Forlenza OV. Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study. International Journal of Geriatric Psychiatry. 33: 769-778. PMID 29411413 DOI: 10.1002/gps.4857 |
0.334 |
|
| 2018 |
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function. Current Drug Metabolism. 19: 641-652. PMID 29283067 DOI: 10.2174/1389200219666171227203225 |
0.76 |
|
| 2017 |
Radanovic M, Stella F, Silva LG, Talib LL, Forlenza OV. Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment. Dementia & Neuropsychologia. 11: 419-425. PMID 29354223 DOI: 10.1590/1980-57642016dn11-040012 |
0.486 |
|
| 2017 |
Costa AC, Joaquim HPG, Forlenza O, Talib LL, Gattaz WF. Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-7. PMID 28922966 DOI: 10.1080/15622975.2017.1369566 |
0.455 |
|
| 2017 |
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European Archives of Psychiatry and Clinical Neuroscience. PMID 28861608 DOI: 10.1007/S00406-017-0838-2 |
0.307 |
|
| 2017 |
Rabelo AG, Teixeira CV, Magalhães TN, Carletti-Cassani AFM, Amato Filho AC, Joaquim HP, Talib LL, Forlenza O, Ribeiro PA, Secolin R, Lopes-Cendes I, Cendes F, Balthazar ML. Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease? The Neuroradiology Journal. 1971400917720465. PMID 28714354 DOI: 10.1177/1971400917720465 |
0.467 |
|
| 2017 |
Cezar NOC, Izbicki R, Cardoso D, Almeida JG, Valiengo L, Camargo MVZ, Forlenza OV, Yassuda MS, Aprahamian I. Frailty in older adults with amnestic mild cognitive impairment as a result of Alzheimer's disease: A comparison of two models of frailty characterization. Geriatrics & Gerontology International. PMID 28488297 DOI: 10.1111/ggi.13028 |
0.399 |
|
| 2017 |
Mirandez RM, Aprahamian I, Talib LL, Forlenza OV, Radanovic M. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease. International Psychogeriatrics. 1-10. PMID 28179036 DOI: 10.1017/S1041610217000102 |
0.496 |
|
| 2017 |
Forlenza OV, Loureiro JC, Pais MV, Stella F. Recent advances in the management of neuropsychiatric symptoms in dementia. Current Opinion in Psychiatry. 30: 151-158. PMID 28079675 DOI: 10.1097/YCO.0000000000000309 |
0.787 |
|
| 2016 |
Borges SM, Radanovic M, Forlenza OV. Correlation between functional mobility and cognitive performance in older adults with cognitive impairment. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-10. PMID 27934540 DOI: 10.1080/13825585.2016.1258035 |
0.334 |
|
| 2016 |
Sanfilippo C, Forlenza O, Zetterberg H, Blennow K. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD. Journal of Neural Transmission (Vienna, Austria : 1996). 123: 1443-1447. PMID 27531278 DOI: 10.1007/s00702-016-1597-3 |
0.439 |
|
| 2016 |
D'Onofrio G, Yu Z, Forlenza OV. Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies. Biomed Research International. 2016: 7242651. PMID 27525276 DOI: 10.1155/2016/7242651 |
0.388 |
|
| 2016 |
Chaves GF, Oliveira AM, Chaves JA, Forlenza OV, Aprahamian I, Nunes PV. Assessment of impairment in activities of daily living in mild cognitive impairment using an individualized scale. Arquivos De Neuro-Psiquiatria. 74: 549-554. PMID 27487375 DOI: 10.1590/0004-282X20160075 |
0.35 |
|
| 2016 |
Forlenza OV, Aprahamian I, de Paula VJ, Hajek T. Lithium, a therapy for AD: current evidence from clinical trials of neurodegenerative disorders. Current Alzheimer Research. PMID 26892289 DOI: 10.2174/1567205013666160219112854 |
0.386 |
|
| 2016 |
Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder. Bipolar Disorders. 18: 71-7. PMID 26877211 DOI: 10.1111/bdi.12367 |
0.437 |
|
| 2016 |
Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZ, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders. 18: 63-70. PMID 26876913 DOI: 10.1111/Bdi.12360 |
0.465 |
|
| 2015 |
Forlenza OV, Radanovic M, Talib LL, Aprahamian I, Diniz BS, Zetterberg H, Gattaz WF. Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 455-63. PMID 27239524 DOI: 10.1016/J.Dadm.2015.09.003 |
0.743 |
|
| 2015 |
Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Therapeutic Advances in Drug Safety. 6: 151-65. PMID 26301069 DOI: 10.1177/2042098615592116 |
0.417 |
|
| 2015 |
de Sousa RT, Streck EL, Forlenza OV, Brunoni AR, Zanetti MV, Ferreira GK, Diniz BS, Portela LV, Carvalho AF, Zarate CA, Gattaz WF, Machado-Vieira R. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder. Neuroscience Letters. 605: 65-8. PMID 26297865 DOI: 10.1016/J.Neulet.2015.08.022 |
0.658 |
|
| 2015 |
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Medicine. 17: 326-32. PMID 26138246 DOI: 10.1007/S12017-015-8361-Y |
0.76 |
|
| 2015 |
Forlenza OV, Teixeira AL, Miranda AS, Barbosa IG, Talib LL, Diniz BS, Gattaz WF. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects. Journal of Alzheimer's Disease : Jad. PMID 25737042 DOI: 10.3233/Jad-150172 |
0.771 |
|
| 2015 |
Borges Sde M, Radanovic M, Forlenza OV. Functional mobility in a divided attention task in older adults with cognitive impairment. Journal of Motor Behavior. 47: 378-85. PMID 25610990 DOI: 10.1080/00222895.2014.998331 |
0.376 |
|
| 2014 |
Aprahamian I, Radanovic M, Nunes PV, Ladeira RB, Forlenza OV. The use of the Clock Drawing Test in bipolar disorder with or without dementia of Alzheimer's type. Arquivos De Neuro-Psiquiatria. 72: 913-8. PMID 25465779 DOI: 10.1590/0004-282X20140153 |
0.418 |
|
| 2014 |
Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Radanovic M, Gattaz WF, Forlenza OV. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 69: 845-51. PMID 25149921 DOI: 10.1093/Geronb/Gbu096 |
0.745 |
|
| 2014 |
Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M, Gattaz WF, Forlenza OV. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. The Journal of Clinical Psychiatry. 75: e672-8. PMID 25093483 DOI: 10.4088/Jcp.13M08741 |
0.694 |
|
| 2014 |
Pereira ML, Camargo Mv, Aprahamian I, Forlenza OV. Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease. Neuropsychiatric Disease and Treatment. 10: 1273-85. PMID 25031536 DOI: 10.2147/NDT.S55371 |
0.388 |
|
| 2014 |
Borges Sde M, Radanovic M, Forlenza OV. Fear of falling and falls in older adults with mild cognitive impairment and Alzheimer's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 22: 312-21. PMID 24992289 DOI: 10.1080/13825585.2014.933770 |
0.379 |
|
| 2014 |
Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Contributions of the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI) for the diagnosis of MCI in Brazil. International Psychogeriatrics. 1-9. PMID 24806666 DOI: 10.1017/S1041610214000726 |
0.383 |
|
| 2014 |
Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS, Gattaz WF, Buchpiguel CA. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. Acs Chemical Neuroscience. 5: 484-9. PMID 24730717 DOI: 10.1021/Cn5000315 |
0.708 |
|
| 2014 |
Stella F, Radanovic M, Balthazar ML, Canineu PR, de Souza LC, Forlenza OV. Neuropsychiatric symptoms in the prodromal stages of dementia. Current Opinion in Psychiatry. 27: 230-5. PMID 24613979 DOI: 10.1097/YCO.0000000000000050 |
0.301 |
|
| 2014 |
Stella F, Radanovic M, Aprahamian I, Canineu PR, de Andrade LP, Forlenza OV. Neurobiological correlates of apathy in Alzheimer's disease and mild cognitive impairment: a critical review. Journal of Alzheimer's Disease : Jad. 39: 633-48. PMID 24254702 DOI: 10.3233/JAD-131385 |
0.497 |
|
| 2014 |
Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLAâ‚‚ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 193-200. PMID 24036895 DOI: 10.1016/J.Jalz.2013.05.647 |
0.784 |
|
| 2014 |
Aprahamian I, Ladeira RB, Diniz BS, Forlenza OV, Nunes PV. Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening tests. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 389-97. PMID 23567429 DOI: 10.1016/j.jagp.2012.08.013 |
0.745 |
|
| 2014 |
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer's disease. Sub-Cellular Biochemistry. 65: 329-52. PMID 23225010 DOI: 10.1007/978-94-007-5416-4_14 |
0.762 |
|
| 2013 |
Aprahamian I, Stella F, Forlenza OV. New treatment strategies for Alzheimer's disease: is there a hope? The Indian Journal of Medical Research. 138: 449-60. PMID 24434253 |
0.389 |
|
| 2013 |
Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W. Mild cognitive impairment (part 2): Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Revista Brasileira De Psiquiatria. 35: 284-294. PMID 24142092 DOI: 10.1590/1516-4446-2012-3505 |
0.784 |
|
| 2013 |
Forlenza OV, Diniz BS, Stella F, Teixeira AL, Gattaz WF. Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 35: 178-85. PMID 23904025 DOI: 10.1590/1516-4446-2012-3503 |
0.771 |
|
| 2013 |
Radanovic M, Pereira FR, Stella F, Aprahamian I, Ferreira LK, Forlenza OV, Busatto GF. White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Review of Neurotherapeutics. 13: 483-93. PMID 23621306 DOI: 10.1586/ern.13.45 |
0.41 |
|
| 2013 |
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric Disease and Treatment. 9: 493-500. PMID 23596350 DOI: 10.2147/NDT.S33086 |
0.715 |
|
| 2013 |
Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Gattaz WF, Forlenza OV. Reduced serum nerve growth factor in patients with late-life depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 493-6. PMID 23570892 DOI: 10.1016/J.Jagp.2013.01.014 |
0.671 |
|
| 2013 |
Forlenza OV, Aprahamian I. Cognitive impairment and dementia in bipolar disorder. Frontiers in Bioscience (Elite Edition). 5: 258-65. PMID 23276987 |
0.423 |
|
| 2013 |
Aprahamian I, Nunes PV, Forlenza OV. Cognitive impairment and dementia in late-life bipolar disorder. Current Opinion in Psychiatry. 26: 120-3. PMID 23132284 DOI: 10.1097/YCO.0b013e32835ac5f6 |
0.36 |
|
| 2013 |
Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Medicine. 15: 115-21. PMID 23055000 DOI: 10.1007/S12017-012-8201-2 |
0.792 |
|
| 2012 |
Diniz BS, Teixeira AL, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research. 46: 1081-5. PMID 22633396 DOI: 10.1016/J.Jpsychires.2012.04.028 |
0.739 |
|
| 2012 |
Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research. 46: 1053-8. PMID 22622071 DOI: 10.1016/J.Jpsychires.2012.04.020 |
0.674 |
|
| 2012 |
Zainaghi IA, Talib LL, Diniz BS, Gattaz WF, Forlenza OV. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 815-9. PMID 22573143 DOI: 10.1016/J.Jalz.2012.05.289 |
0.789 |
|
| 2012 |
Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF. Does lithium prevent Alzheimer's disease? Drugs & Aging. 29: 335-42. PMID 22500970 DOI: 10.2165/11599180-000000000-00000 |
0.762 |
|
| 2012 |
Talib LL, Diniz BS, Zainaghi IA, Forlenza OV, Gattaz WF. A radioenzymatic assay to identify three groups of phospholipase A(2) in platelets. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 86: 149-53. PMID 22498046 DOI: 10.1016/J.Plefa.2012.02.005 |
0.647 |
|
| 2012 |
Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. International Journal of Geriatric Psychiatry. 28: 34-40. PMID 22368034 DOI: 10.1002/gps.3787 |
0.401 |
|
| 2012 |
Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF, Forlenza OV. Circulating Glial-derived neurotrophic factor is reduced in late-life depression. Journal of Psychiatric Research. 46: 135-9. PMID 21963280 DOI: 10.1016/J.Jpsychires.2011.09.007 |
0.681 |
|
| 2011 |
Frota NAF, Nitrini R, Damasceno BP, Forlenza OV, Dias-Tosta E, da Silva AB, Herrera Junior E, Magaldi RM. Criteria for the diagnosis of Alzheimer's disease: Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Dementia & Neuropsychologia. 5: 146-152. PMID 29213739 DOI: 10.1590/S1980-57642011Dn05030002 |
0.456 |
|
| 2011 |
Diniz BS, Nunes PV, Machado-Vieira R, Forlenza OV. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders. Current Opinion in Psychiatry. 24: 473-7. PMID 21918446 DOI: 10.1097/YCO.0b013e32834bb9bd |
0.639 |
|
| 2011 |
Viola LF, Nunes PV, Yassuda MS, Aprahamian I, Santos FS, Santos GD, Brum PS, Borges SM, Oliveira AM, Chaves GF, Ciasca EC, Ferreira RC, Paula VJ, Takeda OH, Mirandez RM, ... ... Forlenza OV, et al. Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease. Clinics (Sã£O Paulo, Brazil). 66: 1395-400. PMID 21915490 DOI: 10.1590/S1807-59322011000800015 |
0.371 |
|
| 2011 |
Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 198: 351-6. PMID 21525519 DOI: 10.1192/Bjp.Bp.110.080044 |
0.771 |
|
| 2011 |
de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, Forlenza OV, Gattaz WF, Machado-Vieira R. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neuroscience Letters. 494: 54-6. PMID 21362460 DOI: 10.1016/J.Neulet.2011.02.054 |
0.662 |
|
| 2011 |
Diniz BS, Talib LL, Joaquim HP, de Paula VR, Gattaz WF, Forlenza OV. Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 216-22. PMID 21314327 DOI: 10.3109/15622975.2010.551408 |
0.716 |
|
| 2011 |
Aprahamian I, Diniz BS, Izbicki R, Radanovic M, Nunes PV, Forlenza OV. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. International Journal of Geriatric Psychiatry. 26: 403-8. PMID 20658476 DOI: 10.1002/gps.2540 |
0.784 |
|
| 2011 |
Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HP, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of Psychiatric Research. 45: 220-4. PMID 20576277 DOI: 10.1016/J.Jpsychires.2010.06.002 |
0.775 |
|
| 2010 |
Forlenza OV, Diniz BS, Gattaz WF. Diagnosis and biomarkers of predementia in Alzheimer's disease. Bmc Medicine. 8: 89. PMID 21176189 DOI: 10.1186/1741-7015-8-89 |
0.78 |
|
| 2010 |
Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 1305-11. PMID 20930310 DOI: 10.3233/Jad-2010-100921 |
0.775 |
|
| 2010 |
Yassuda MS, Flaks MK, Viola LF, Pereira FS, Memória CM, Nunes PV, Forlenza OV. Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil. International Psychogeriatrics / Ipa. 22: 1003-11. PMID 20598195 DOI: 10.1017/S1041610210001055 |
0.333 |
|
| 2010 |
Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Izzo G, Gattaz WF. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 774-80. PMID 20491609 DOI: 10.3109/15622971003797241 |
0.776 |
|
| 2010 |
Pereira FS, Oliveira AM, Diniz BS, Forlenza OV, Yassuda MS. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 25: 335-43. PMID 20484096 DOI: 10.1093/arclin/acq029 |
0.737 |
|
| 2010 |
Forlenza OV, Diniz BS, Talib LL, Radanovic M, Yassuda MS, Ojopi EB, Gattaz WF. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 32: 216-22. PMID 20414590 DOI: 10.1590/S1516-44462010005000002 |
0.798 |
|
| 2010 |
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatric Research. 44: 917-20. PMID 20338581 DOI: 10.1016/J.Jpsychires.2010.02.008 |
0.671 |
|
| 2010 |
Pereira FS, Yassuda MS, Oliveira AM, Diniz BS, Radanovic M, Talib LL, Gattaz WF, Forlenza OV. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. Journal of the International Neuropsychological Society : Jins. 16: 297-305. PMID 20175938 DOI: 10.1017/S1355617709991330 |
0.777 |
|
| 2010 |
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 550-5. PMID 20109109 DOI: 10.3109/15622970903544620 |
0.68 |
|
| 2010 |
Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 172-6. PMID 20104073 DOI: 10.1097/Jgp.0B013E3181C2947F |
0.689 |
|
| 2009 |
Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiology of Aging. 32: 1733-41. PMID 20005012 DOI: 10.1016/j.neurobiolaging.2009.11.008 |
0.759 |
|
| 2009 |
Forlenza OV, Diniz BS, Talib LL, Mendonça VA, Ojopi EB, Gattaz WF, Teixeira AL. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 28: 507-12. PMID 19996595 DOI: 10.1159/000255051 |
0.733 |
|
| 2009 |
Ladeira RB, Diniz BS, Nunes PV, Forlenza OV. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. Clinics (Sã£O Paulo, Brazil). 64: 967-73. PMID 19841703 DOI: 10.1590/S1807-59322009001000006 |
0.737 |
|
| 2009 |
Forlenza OV, Diniz BS, Nunes PV, Memória CM, Yassuda MS, Gattaz WF. Diagnostic transitions in mild cognitive impairment subtypes. International Psychogeriatrics / Ipa. 21: 1088-95. PMID 19691909 DOI: 10.1017/S1041610209990792 |
0.77 |
|
| 2009 |
Radanovic M, Diniz BS, Mirandez RM, Novaretti TM, Flacks MK, Yassuda MS, Forlenza OV. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education. International Psychogeriatrics. 21: 1081-7. PMID 19619390 DOI: 10.1017/S1041610209990639 |
0.77 |
|
| 2009 |
Diniz BS, Nunes PV, Yassuda MS, Forlenza OV. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dementia and Geriatric Cognitive Disorders. 27: 224-31. PMID 19225236 DOI: 10.1159/000203346 |
0.743 |
|
| 2009 |
Diniz BS, Pinto JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease European Archives of Psychiatry and Clinical Neuroscience. 259: 248-256. PMID 19224111 DOI: 10.1007/S00406-008-0864-1 |
0.779 |
|
| 2009 |
Yassuda MS, Diniz BS, Flaks MK, Viola LF, Pereira FS, Nunes PV, Forlenza OV. Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 24: 71-9. PMID 19041220 DOI: 10.1093/arclin/acp009 |
0.652 |
|
| 2009 |
Schaeffer EL, Forlenza OV, Gattaz WF. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease Psychopharmacology. 202: 37-51. PMID 18853146 DOI: 10.1007/S00213-008-1351-0 |
0.379 |
|
| 2009 |
Forlenza OV, Cretaz E, Diniz BS. [The use of antipsychotics in patients with dementia]. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 30: 265-70. PMID 18833428 DOI: 10.1590/s1516-44462008000300014 |
0.697 |
|
| 2009 |
Diniz BS, Pinto Júnior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 172-82. PMID 17886169 DOI: 10.1080/15622970701535502 |
0.773 |
|
| 2008 |
Abreu ID, Nunes PV, Diniz BS, Forlenza OV. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 30: 346-9. PMID 19142410 |
0.728 |
|
| 2008 |
Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, Radanovic M, Abreu ID, Borelli DT, Gattaz WF, Forlenza OV. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 30: 316-21. PMID 19142405 DOI: 10.1590/S1516-44462008000400003 |
0.749 |
|
| 2008 |
Forlenza OV, Chiu E. Mild cognitive impairment: a concept ready to move on? Current Opinion in Psychiatry. 21: 529-32. PMID 18852557 DOI: 10.1097/YCO.0b013e328316c2ab |
0.343 |
|
| 2008 |
Nunes PV, Diniz BS, Radanovic M, Abreu ID, Borelli DT, Yassuda MS, Forlenza OV. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. International Journal of Geriatric Psychiatry. 23: 1127-33. PMID 18464287 DOI: 10.1002/gps.2038 |
0.741 |
|
| 2007 |
Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-mental State Examination performance in mild cognitive impairment subtypes. International Psychogeriatrics / Ipa. 19: 647-56. PMID 17502007 DOI: 10.1017/S104161020700542X |
0.723 |
|
| 2007 |
Zainaghi IA, Forlenza OV, Gattaz WF. Abnormal APP processing in platelets of patients with Alzheimer's disease: Correlations with membrane fluidity and cognitive decline Psychopharmacology. 192: 547-553. PMID 17356877 DOI: 10.1007/S00213-007-0748-5 |
0.334 |
|
| 2006 |
Flaks MK, Yassuda MS, Regina ACB, Cid CG, Camargo CHP, Gattaz WF, Forlenza OV. The short cognitive performance test (SKT): A preliminary study of its psychometric properties in Brazil International Psychogeriatrics. 18: 121-133. PMID 16255841 DOI: 10.1017/S1041610205002577 |
0.41 |
|
| 2005 |
Engelhardt E, Brucki SM, Cavalcanti JL, Forlenza OV, Laks J, Vale FA. [Treatment of Alzheimer's disease: recommendations and suggestions of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology]. Arquivos De Neuro-Psiquiatria. 63: 1104-12. PMID 16400437 DOI: 10.1590/s0004-282x2005000600035 |
0.399 |
|
| Show low-probability matches. |